Xconomy | Boston - Business + Technology in the Exponential Economy

Xconomy Forum: How to Build a Life Sciences Company

Sept. 23, 2008 - Agenda
7:30 – 8:10 Registration and coffee
8:10 – 8:15 Welcome
Charles Wilson, VP Strategic Alliances, Novartis Institutes for Biomedical Research
8:15 – 8:20 Introduction
Bob Buderi, Founder, CEO, and Editor in Chief, Xconomy
8:20 – 8:35 Case Study: Enlight Biosciences
New Business Model for Technology Development
David Steinberg, CEO, Enlight Biosciences; Senior Principal, PureTech Ventures
8:35 – 8:50 Case Study: Fate Therapeutics
Building a Company Around a Community of Founders
Amir Nashat, General Partner, Polaris Venture Partners
Alex Rives, Associate, ARCH Venture Partners; Co-Founder and Founding President, Fate Therapeutics
8:50 – 9:30 Panel: New Approaches to Incubation
Luke Timmerman, National Biotech Editor, Xconomy (moderator)
Nils Bergenhem, Chief Scientific Officer, Escoublac
Clifford J. Robinson, Director, Business Incubation, Boston University
David Schubert, Chief Business Officer, Accelerator Corporation
Chuck Wilson, VP Strategic Alliances, Novartis
9:30 – 9:45 Case Study: Cambria Pharmaceuticals
Cents and Sensibility: The Role of Non-Dilutive Funding in a Biotech Startup
Leo Liu, Founder and CEO, Cambria Pharmaceuticals
9:45 – 10:05 Break
10:05 – 10:20 Case study: Diagnostics-For-All
The Advantages and Challenges of Choosing the Non-Profit Route
Myer Berlow, CEO, Nano-Terra; Director, Diagnostics-For-All
10:20 – 10:35 Case study: RXi Pharmaceuticals
RXi Pharmaceuticals’ Story of How to Build a Life Sciences Company
Tod Woolf, CEO, RXi Pharmaceuticals
10:35 – 11:15 Panel: New Strategies for Getting Off the Ground
Carmichael Roberts, General Partner, North Bridge Venture Partners (moderator)
Leo Liu, Founder and CEO, Cambria Pharmaceuticals
Alex Rives, Associate, ARCH Venture Partners; Co-Founder and Founding President, Fate Therapeutics
David Steinberg, CEO, Enlight Biosciences; Senior Principal, PureTech Ventures
Myer Berlow, CEO, Nano-Terra; Director, Diagnostics-For-All
Tod Woolf, CEO, RXi Pharmaceuticals
11:15 – 11:30 Spotlight presentation: Quanterix
Nick Naclerio, Co-Founder, CEO, and Chairman, Quanterix
11:30 – 12:15 Keynote Chat
Robert Langer, Institute Professor, MIT
Terry McGuire, Co-founder and Managing General Partner, Polaris Venture Partners
12:15 – 1:30 Networking Lunch
CLICK HERE FOR MORE DETAILS AND TO REGISTER.


    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2008 Xconomy. All rights reserved. Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.